2021年论文发表一览表 |
序号 |
作者，题目等 |
年份 |
期刊名称 |
IF（当年） |
1 |
Zhang H, Dai S, Liang X, Li J, Chen Y. Mechanistic Insights into the Preference for Tandem Binding Sites in DNA Recognition by FOXM1 |
2021 |
J Mol Biol. |
5.469 |
2 |
Wang H, Lu L, Liang X, Chen Y. Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis |
2021 |
Cancer ImmunolImmunother |
6.968 |
3 |
Zhang Z, Wang Y, Chen X, Song X, Tu Z, Chen Y, Zhang Z, Ding K. Characterization of an aromatic trifluoromethyl ketone as a new warhead for covalently reversible kinase inhibitor design. |
2021 |
Bioorg Med Chem |
3.641 |
4 |
Dai S, Qu L, Li J, Chen Y. Toward a mechanistic understanding of DNA binding by forkhead transcription factors and its perturbation by pathogenic mutations. |
2021 |
Nucleic Acids Res |
16.971 |
5 |
Li M, Peng F, Wang G, Liang X, Shao M, Chen Z, Chen Y. Coupling of Cell Surface Biotinylation and SILAC-Based Quantitative Proteomics Identified Myoferlin as a Potential Therapeutic Target for Nasopharyngeal Carcinoma Metastasis |
2021 |
Front Cell Dev Biol |
6.684 |
6 |
Cheng Z, Li M, Dey R, Chen Y. Nanomaterials for cancer therapy: current progress and perspectives |
2021 |
J Hematol Oncol |
17.388 |
7 |
Jiang L, Zhang H, Xiao D, Wei H, Chen Y. Farnesoid X receptor (FXR): Structures and ligands |
2021 |
Comput Struct Biotechnol J |
7.271 |
8 |
8: Wang H, Guo M, Wei H, Chen Y. Targeting MCL-1 in cancer: current status and perspectives |
2021 |
J Hematol Oncol |
17.388 |
9 |
Wei H, Qu L, Dai S, Li Y, Wang H, Feng Y, Chen X, Jiang L, Guo M, Li J, Chen Z, Chen L, Zhang Y, Chen Y. Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis |
2021 |
Nat Commun |
14.919 |
10 |
Deng W, Chen X, Jiang K, Song X, Huang M, Tu ZC, Zhang Z, Lin X, Ortega R, Patterson AV, Smaill JB, Ding K, Chen S, Chen Y, Lu X. Investigation of Covalent Warheads in the Design of 2-Aminopyrimidine-based FGFR4 Inhibitors |
2021 |
ACS Med Chem Lett |
4.435 |
11 |
Huang H, Zhao J, Wang TY, Zhang S, Zhou Y, Rao Y, Qin C, Liu Y, Chen Y, Xia Z, Feng P. Species-Specific Deamidation of RIG-I Reveals Collaborative Action between Viral and Cellular Deamidases in HSV-1 Lytic Replication |
2021 |
mBio |
7.867 |
12 |
Zhou M, Zheng H, Li Y, Huang H, Min X, Dai S, Zhou W, Chen Z, Xu G, Chen Y. Discovery of a novel AR/HDAC6 dual inhibitor for prostate cancer treatment. |
2021 |
Aging (Albany NY) |
5.682 |
13 |
Chen X, Liu Y, Zhang L, Chen D, Dong Z, Zhao C, Liu Z, Xia Q, Wu J, Chen Y, Zheng X, Cai Y. Design, synthesis, and biological evaluation of indazole derivatives as selective and potent FGFR4 inhibitors for the treatment of FGF19-driven hepatocellular cancer |
2021 |
Eur J Med Chem |
6.514 |
14 |
Li J, Dai S, Chen X, Liang X, Qu L, Jiang L, Guo M, Zhou Z, Wei H, Zhang H, Chen Z, Chen L, Chen Y. Mechanism of forkhead transcription factors binding to a novel palindromic DNA site |
2021 |
Nucleic Acids Res |
16.971 |
15 |
Yue S, Li Y, Chen X, Wang J, Li M, Chen Y, Wu D. FGFR-TKI resistance in cancer: current status and perspectives |
2021 |
J Hematol Oncol |
17.388 |
16 |
Guo M, Dai S, Wu D, Duan Y, Li J, Qu L, Jiang L, Chen Z, Chen X, Chen Y. Characterization of ibrutinib as a non-covalent inhibitor of SRC-family kinases |
2021 |
Bioorg Med Chem Lett |
2.823 |
17 |
Jiang L, Xiao D, Li Y, Dai S, Qu L, Chen X, Guo M, Wei H, Chen Y. Structural basis of tropifexor as a potent and selective agonist of farnesoid X receptor |
2021 |
Biochem Biophys Res Commun |
3.575 |
18 |
Tsai CF(#), Zhang PF(#), Scholten D(#), Martin K, Wang YT, Zhao R, Chrisler WB, Patel DB, Dou M, Jia Y, Reduzzi C, Liu X, Moore RJ, Burnum-Johnson KE, Lin MH, Hsu CC, Jacobs JM, Kagan J, Srivastava S, Rodland KD, Steven Wiley H, Qian WJ, Smith RD, Zhu Y, Cristofanilli M, Liu T*, Liu H*, Shi T*. Surfactant-assisted one-pot sample preparation for label-free single-cell proteomics |
2021 |
Commun Biol. |
6.268 |
19 |
He Y, Liu RJ, Yang M, Bi W, Zhou LY, Zhang S, Jin J, Liang XJ, Zhang PF*. Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis |
2021 |
Front. Oncol |
6.244 |
20 |
Li B#, Zhou M#, Wang J, Xu H and Yang M *, Suppressing ERK Pathway Impairs Glycochenodeoxycholate-Mediated Survival and Drug-Resistance in Hepatocellular Carcinoma Cells |
2021 |
Front. Oncol |
6.244 |
21 |
Maojun Zhou #, Hao Zheng #, Yubin Li # ,Huichao Huang, Xiaoli Min, Shuyan Dai, Wenqiang Zhou, Zhuchu Chen, Guangyu Xu*, Yongheng Chen*. Discovery of a novel AR/HDAC6 dual inhibitor for prostate cancer treatment |
2021 |
Aging |
5.682 |
22 |
Yun Wu #, Kun Cao #, Wei Zhang, Guangxian Zhang, Maojun Zhou *, Protective and anti-aging effects of five cosmeceutical peptide mixtures on hydrogen peroxide-induced premature senescence in human skin fibroblasts. |
2021 |
Skin Pharmacology and Physiology |
3.479 |
23 |
Manyi Yang, Yubin Li, Longfei Liu, Maojun Zhou *, A novel M-superfamily proline-rich conotoxin that can simultaneously affect sodium, potassium and calcium currents |
2021 |
J Venom Anim Toxins incl Trop Dis |
2.831 |
24 |
Yun Wu #, Yuanyuan Qiang #, Guangxian Zhang*, Maojun Zhou *, Acute toxicity and micronucleus test of conotoxin lt14a in mice |
2021 |
Basic Clin Pharmacol Toxicol |
4.080 |
25 |
Yuanyuan Zhu(#), Zhangya Pu, Zhenfen Li, Ying Lin, Ning Li, Fang Peng(*). Comprehensive Analysis of the Expression and Prognosis Value of Chromobox Family Members in Clear Cell Renal Cell Carcinoma |
2021 |
Front Oncol. |
6.244 |
26 |
.Yinmiao Wang(#), Yuanyuan Zhu, Zhangya Pu, Zhenfen Li, Ying Deng, Ning Li, Fang Peng(*). Soluble resistance-related calcium-binding protein participates in multiple diseases via protein-protein interactions |
2021 |
Biochimie |
4.079 |
27 |
Yuanyuan Zhu(#), Zhangya Pu, Guoqiang Wang, Yubin Li, Yinmiao Wang, Ning Li, Fang Peng(*). FAM3C: an emerging biomarker and potential therapeutic target for cancer |
2021 |
Biomark Med |
2.851 |
28 |
Wenyu Yin(#), Jiao Yuan, Zhimin Zhang, Cheng Mei, Wei Xu, Yongxiang Tang, Fang Peng(*), Ning Li(*). 18F-fluorodeoxyglucose positron emission tomography–computed tomography for assessing organ distribution of stressed red blood cells in mice |
2021 |
Sci Rep |
4.379 |
29 |
Zhangya Pu(#), Yuanyuan Zhu, Xiaofang Wang, Yun Zhong, Fang Peng(*), Yiya Zhang(*). Identification of Prognostic Biomarkers and Correlation With Immune Infiltrates in Hepatocellular Carcinoma Based on a Competing Endogenous RNA Network |
2021 |
Front Genet |
4.599 |
30 |
Maoyu Li(#) , Fang Peng(#), Guoqiang Wang(#), Xujun Liang, Meiying Shao, Zhuchu Chen(*), Yongheng Chen(*).Coupling of Cell Surface Biotinylation and SILAC-Based Quantitative Proteomics Identified Myoferlin as a Potential Therapeutic Target for Nasopharyngeal Carcinoma Metastasis |
2021 |
Front Cell Dev Biol |
6.684 |
31 |
Jinzhong Zhang(#); Xiuzhi Zhang(#); Lingxiao Wang; Chunyan Kang; Ningning Li; Zhefeng Xiao(*); Liping Dai(*), Multiomics-based analyses of KPNA2 highlight its multiple potentials in hepatocellular carcinoma |
2021 |
PeerJ |
2.98 |
32 |
He Y, Liu R, Yang M, Bi W, Zhou L, Zhang S, Jin J, Liang X, Zhang P. Identification of VWF as a Novel Biomarker in Lung Adenocarcinoma by Comprehensive Analysis |
2021 |
Front Oncol |
6.244 |
